Ignite Creation Date:
2024-05-05 @ 4:53 PM
Last Modification Date:
2024-10-26 @ 9:25 AM
Study NCT ID:
NCT00337545
Status:
COMPLETED
Last Update Posted:
2007-10-10
First Post:
2006-06-15
Brief Title:
Phase II Trial of RAD001 in Refractory Colorectal Cancer
Sponsor:
Swedish Medical Center
Organization:
Swedish Medical Center
Study Overview
Official Title:
Phase II Trial of RAD001 in Patients With Refractory Colorectal Cancer
Status:
COMPLETED
Status Verified Date:
2007-10
Last Known Status:
None
Delayed Posting:
No
If Stopped, Why?:
Not Stopped
Has Expanded Access:
False
If Expanded Access, NCT#:
N/A
Has Expanded Access, NCT# Status:
N/A
Acronym:
None
Brief Summary:
Single center open-label study of an oral agent RAD001 in subjects with metastatic colorectal cancer refractory to at least 2 standard chemobiologic regimens
Detailed Description:
Study is completed and closed
Study Oversight
Has Oversight DMC:
None
Is a FDA Regulated Drug?:
None
Is a FDA Regulated Device?:
None
Is an Unapproved Device?:
None
Is a PPSD?:
None
Is a US Export?:
None
Is an FDA AA801 Violation?:
None
Secondary IDs
| Secondary ID | Type | Domain | Link |
|---|---|---|---|
| Swedish Cancer Institute 05128 | None | None | None |